Research & Development



  謝寧大笑一聲道︰“不知道,是將軍下的軍令,哈哈哈,力氣不小,再來一下!”   霍去病冷笑道︰“這是十年來你們該上繳的進貢,以後,每年五十頭牛,五百只羊,五百張羊皮!如果不想讓我們來,你們就該送去白登山!”人人摸   “她一定很疼愛她的孫兒……”人人看   甦稚在一邊不斷地糾正親兵們的捏腳手法,老不死的們一個個舒服的齜牙咧嘴。   趙破奴剛來,有些放不開,勉強吃了半屜包子就說已經吃飽了,準備去干活了。超碰在线   唯獨他,因為那一幕,被謝長川將他以前立下的功勞一筆勾銷了。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo